Michael Higgins
Stock Analyst at Ladenburg Thalmann
(1.82)
# 3,180
Out of 5,182 analysts
22
Total ratings
33.33%
Success rate
5.24%
Average return
Main Sectors:
Stocks Rated by Michael Higgins
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VRDN Viridian Therapeutics | Downgrades: Neutral | n/a | $13.42 | - | 4 | May 9, 2024 | |
| FBRX Forte Biosciences | Upgrades: Buy | $69 | $28.19 | +143.88% | 3 | Apr 8, 2024 | |
| OVID Ovid Therapeutics | Reiterates: Buy | $7 | $2.79 | +150.90% | 1 | May 2, 2023 | |
| SCYX SCYNEXIS | Reiterates: Buy | $15 | $0.99 | +1,414.69% | 1 | Apr 3, 2023 | |
| ARTL Artelo Biosciences | Reiterates: Buy | $1,080 | $3.39 | +31,758.41% | 2 | Apr 3, 2023 | |
| RYTM Rhythm Pharmaceuticals | Reiterates: Buy | $35 | $81.81 | -57.22% | 3 | Mar 2, 2023 | |
| PTN Palatin Technologies | Maintains: Buy | $2 → $50 | $20.23 | +147.16% | 1 | Sep 9, 2022 | |
| PHGE BiomX | Maintains: Buy | $2,470 → $1,520 | $0.79 | +192,402.53% | 2 | May 12, 2022 | |
| NVAX Novavax | Downgrades: Sell | $105 | $8.04 | +1,205.97% | 2 | Aug 5, 2020 | |
| VIRT Virtu Financial | Upgrades: Buy | $29 | $48.12 | -39.73% | 2 | Jan 4, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | n/a | $5.12 | - | 1 | Sep 27, 2017 |
Viridian Therapeutics
May 9, 2024
Downgrades: Neutral
Price Target: n/a
Current: $13.42
Upside: -
Forte Biosciences
Apr 8, 2024
Upgrades: Buy
Price Target: $69
Current: $28.19
Upside: +143.88%
Ovid Therapeutics
May 2, 2023
Reiterates: Buy
Price Target: $7
Current: $2.79
Upside: +150.90%
SCYNEXIS
Apr 3, 2023
Reiterates: Buy
Price Target: $15
Current: $0.99
Upside: +1,414.69%
Artelo Biosciences
Apr 3, 2023
Reiterates: Buy
Price Target: $1,080
Current: $3.39
Upside: +31,758.41%
Rhythm Pharmaceuticals
Mar 2, 2023
Reiterates: Buy
Price Target: $35
Current: $81.81
Upside: -57.22%
Palatin Technologies
Sep 9, 2022
Maintains: Buy
Price Target: $2 → $50
Current: $20.23
Upside: +147.16%
BiomX
May 12, 2022
Maintains: Buy
Price Target: $2,470 → $1,520
Current: $0.79
Upside: +192,402.53%
Novavax
Aug 5, 2020
Downgrades: Sell
Price Target: $105
Current: $8.04
Upside: +1,205.97%
Virtu Financial
Jan 4, 2019
Upgrades: Buy
Price Target: $29
Current: $48.12
Upside: -39.73%
Sep 27, 2017
Reinstates: Buy
Price Target: n/a
Current: $5.12
Upside: -